Novel vaccine vectors for HIV-1. - Suppr | 超能文献

Novel vaccine vectors for HIV-1.

作者信息

Barouch Dan H, Picker Louis J

出版信息

Nat Rev Microbiol. 2017 Oct 12;15(11):696. doi: 10.1038/nrmicro.2017.134.

DOI:10.1038/nrmicro.2017.134

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Novel vaccine vectors for HIV-1.

Nat Rev Microbiol. 2017 Oct 12;15(11):696. doi: 10.1038/nrmicro.2017.134.

2

HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates.基于表达三聚体gp140和Gag衍生病毒样颗粒的复制能力重组痘病毒NYVAC-C-KC或缺乏抑制I型干扰素的病毒分子B19的HIV/AIDS候选疫苗，在非人灵长类动物中激活相关的HIV-1特异性B和T细胞免疫功能。

J Virol. 2017 Apr 13;91(9). doi: 10.1128/JVI.02182-16. Print 2017 May 1.

3

Construction and evaluation of novel rhesus monkey adenovirus vaccine vectors.新型恒河猴腺病毒疫苗载体的构建与评价

J Virol. 2015 Feb;89(3):1512-22. doi: 10.1128/JVI.02950-14. Epub 2014 Nov 19.

4

Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles.表达C亚型三聚体可溶性gp140（ZM96）和Gag（ZM96）-Pol-Nef（CN54）作为病毒样颗粒的新型基于NYVAC的HIV/AIDS候选疫苗的病毒学和免疫学特性

J Virol. 2015 Jan 15;89(2):970-88. doi: 10.1128/JVI.02469-14. Epub 2014 Oct 29.

5

Enhanced expression of HIV and SIV vaccine antigens in the structural gene region of live attenuated rubella viral vectors and their incorporation into virions.增强 HIV 和 SIV 疫苗抗原在活减毒风疹病毒载体结构基因区的表达及其在病毒粒子中的掺入。

Vaccine. 2013 Apr 19;31(17):2119-25. doi: 10.1016/j.vaccine.2013.02.055. Epub 2013 Mar 6.

6

Live rubella vectors can express native HIV envelope glycoproteins targeted by broadly neutralizing antibodies and prime the immune response to an envelope protein boost.活风疹病毒载体可表达被广泛中和抗体靶向的天然 HIV 包膜糖蛋白，并引发针对包膜蛋白加强的免疫反应。

Vaccine. 2018 Aug 16;36(34):5166-5172. doi: 10.1016/j.vaccine.2018.07.010. Epub 2018 Jul 20.

7

Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C.针对C亚型HIV-1包膜糖蛋白/ gag - Pol - Nef抗原的新型HIV/AIDS候选疫苗的产生及免疫原性

Vaccine. 2007 Mar 1;25(11):1969-92. doi: 10.1016/j.vaccine.2006.11.051. Epub 2006 Dec 6.

8

Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates.痘病毒NYVAC和ALVAC载体在非人灵长类动物中与Env蛋白进行初免-加强联合免疫时表达相同HIV-1 C亚型免疫原的头对头比较。

J Virol. 2015 Aug;89(16):8525-39. doi: 10.1128/JVI.01265-15. Epub 2015 Jun 3.

9

Replicating viral vectors as HIV vaccines: summary report from the IAVI-sponsored satellite symposium at the AIDS vaccine 2009 conference.作为艾滋病疫苗的复制型病毒载体：2009年艾滋病疫苗会议上由国际艾滋病疫苗倡议组织主办的卫星研讨会总结报告

Biologicals. 2010 Jul;38(4):511-21. doi: 10.1016/j.biologicals.2010.03.005.

10

Viral vectors as potential HIV-1 vaccines.作为潜在HIV-1疫苗的病毒载体

FEMS Microbiol Lett. 2001 Jun 25;200(2):123-9. doi: 10.1111/j.1574-6968.2001.tb10703.x.

引用本文的文献

1

Antigen processing and presentation in HIV infection.HIV 感染中的抗原加工和呈递。

Mol Immunol. 2019 Sep;113:67-74. doi: 10.1016/j.molimm.2018.03.027. Epub 2018 Apr 7.

本文引用的文献

1

Novel vaccine vectors for HIV-1.用于 HIV-1 的新型疫苗载体。

Nat Rev Microbiol. 2014 Nov;12(11):765-71. doi: 10.1038/nrmicro3360. Epub 2014 Oct 8.